Corporate Compliance Programs: The Importance of Being Effective
Brian Dahl Now more than ever, pharmaceutical companies must not only have an effective Corporate Compliance Program in place, but senior management and boards of directors at these companies must ...
View ArticleProstate Cancer Drug Winners and Losers at ASCO GU
Pieter Droppert The latest clinical research in prostate cancer is being presented at the American Society of Clinical Oncology Genitorinary Cancers Symposium (ASCO GU) in Orlando, FL. Presentations...
View ArticleTrends to Watch at This Year’s Big AGBT Meeting
Nathaniel Pearson Mainstream news stories often mistake technology for science. Such conflation likely reflects how gizmos and knowledge, like arteries and veins, form a virtuous cycle: understanding...
View ArticleThe Academy Awards: Biopharma Edition
Stewart Lyman Academy Award season is upon us, with the Oscars being polished up in anticipation of the big night. Who knows which Hollywood heavyweights and newcomers will be recognized ...
View ArticleShedding Baggage, Alnylam Turns a Corner
Steve Dickman What convinces investors that a drug discovery company is likely to bring products to the market, and rewards to shareholders? It comes down to just a few things: ...
View ArticleAs MWC Opens in Barcelona, We’re All on the Eve of Disruption
Ricardo Tavares It’s sunny but cold in Barcelona today, as more than 72,000 telecom and technology professionals arrive for the first day of the Mobile World Congress. They come for ...
View ArticleFinding Parallels in Baseball and Drug Development
Kyle Serikawa Consider a candidate. Selecting that candidate takes thousands of hours of time and research–checking background, verifying data, assessing probabilities, projecting futures. Once...
View ArticleFour Things I Learned From Studying Innovation in 3 U.S. Cities
View the Slideshow Mary Walshok I’ve spent most of my career studying how key regions around the world have harnessed their indigenous research capabilities, entrepreneurial spirit, and industrial...
View ArticleHas The Pendulum Swung Too Far in Favor of Rare Diseases?
Stewart Lyman As a politician, one of the worst things you can be accused of is being a flip-flopper, a person who changes their mind on one or more issues. ...
View ArticleExcess Healthcare Spending Is Undermining Innovation
Rob Arnold I read Luke Timmerman’s article yesterday on ProCure with mixed emotions. My first emotion was that of deep gratitude for the men and women who commit their lives ...
View ArticleFighting a Global War on Rare Diseases
Francois Nader Are we winning the war against rare, or “orphan,” diseases? A casual observer could be forgiven for thinking so, given the drumroll of news. The crescendo came in ...
View ArticleDrug Development: Let’s Play!
Kyle Serikawa My 9-year-old son is addicted to “Let’s Play” videos on YouTube. You watch videos that take you through level after level of a video game, giving you ...
View ArticleBuild Credibility As You Build Your Business
Dan Eramian Whether you are a first-time entrepreneur or a veteran company executive, the one aspect of growing a business and raising capital, or selling a product rarely discussed at ...
View ArticleStill Waiting for the Ships to Come in at Third Rock Ventures
Standish Fleming Third Rock Ventures was in the enviable position of turning away some institutional investors when the life sciences venture firm recently closed on $516 million for its third ...
View ArticleENCODE and the Truth
Richard Gayle Constant facts of all scientific endeavors – Nature always wins. The truth will come out. An absorbing article last month in The Scientist called The A@#hole Scientist ...
View ArticleHealthcare IT: Making Good Progress
Sramana Mitra The cost of healthcare administration is a hot issue in America. According to the Center for American progress, in the U.S. healthcare system an estimated $361 billion ...
View ArticleSEC’s New Social Media Guidance: Sensible, Fair, Inevitable
Brad Loncar Give the SEC a lot of credit…the headline they chose for their press release yesterday about public companies using social media could not have been more clear: “SEC ...
View ArticleSequencing Seattle: An Idea for the Future of the Northwest
Kyle Serikawa Let me make a modest proposal: Seattle should commit to sequencing and interpreting the genomes of every willing member of its population and should do it within the ...
View ArticleNow is the Time to Push for a Robot-Assisted Surgery Revolution
Jeff Berkley As recently reported in The Wall Street Journal, The New York Times, and Bloomberg News, there is a controversy brewing over robotic surgery and whether it is ...
View ArticleLighting the Way to Better Understanding of the Brain
Karlyn Beer We are enamored by our brains. Arguably the most complex system in the universe that is made up of over 80 billion neurons, the brain is a complex ...
View Article
